News

Target Medicals has secured a follow-on investment deal from Unicorn Capital Partners

Unicorn Capital Partners VC and AstraZeneca invest in Target Medicals

Target Medicals Group is among finalists of the Start-Up Stadium event at the 2020 BIO International Convention Digital

We are very excited about our new scientific collaboration with industry leaders!

Target Medicals Group is among finalists of global innovation competition within RESI Europe 2020.

Our project is selected to present at BIO-Europe 2019 in the Next Generation track.

1st place in Patents Power competition, organised by Bayer AG.

Target Medicals is participating in largest biotech business partnering event of 2019

As a winner of AstraZeneca Startup Challenge 2018 Crystera took part in a Demo Day in Cambridge, UK

Target Medicals is participating in largest business partnering event.

Target Medicals is proud to be among biotech companies selected by Bayer for CoLaborator program.

Target Medicals is presenting on 43rd Meeting of the International Aldosterone Conference, which will take place in Chicago, March 15-16, 2018.

Target Medicals is invited to present on 2018 Biotech Showcase in San Francisco during JP Morgan week.

Our satellite project is a contestant of StartUp Slam!, organised by Johnson & Johnson and EBD Group.

Target Medicals is selected to present at BIO-Europe 2017 in the Next Generation track.

Target Medicals takes part in 2017 BIO International Convention.

Target Medicals is participating in BIO-Europe 2016 conference.